acetylcysteine has been researched along with Autism in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Bishayee, K; Huh, SO; Kang, J | 1 |
| Deng, YN; He, XL; Li, YF; Wang, LJ; Wang, T; Zhang, YH | 1 |
| Bristow, GC; Dawson, N; Mitchell, EJ; Morris, BJ; Openshaw, RL; Pratt, JA; Thomson, DM | 1 |
| Cheng, YS; Hung, KC; Sun, CK | 1 |
| Cui, W; Wen, X; Zhai, Q; Zhang, T; Zhang, Y | 1 |
| Aldbass, AM; Bhat, RS; El-Ansary, A | 1 |
| Frye, RE; James, SJ; Melnyk, S; Rose, S; Slattery, J; Tippett, M; Wynne, R | 1 |
| Marler, S; Sanders, KB; Veenstra-VanderWeele, J | 1 |
| Bent, S; Hendren, RL | 1 |
| Racz, R; Sohoni, P; Sweet, BV | 1 |
| Berk, M; Dean, OM; Dodd, S; Gray, KM; Mohebbi, M; Tonge, BJ; Vick, T; Villagonzalo, KA | 1 |
| Frazier, TW; Fung, LK; Hardan, AY; Herzenberg, LA; Libove, RA; Nair, S; Obukhanych, TV; Tirouvanziam, R | 1 |
| Berk, M; Bush, AI; Dean, OM | 1 |
2 review(s) available for acetylcysteine and Autism
| Article | Year |
|---|---|
Complementary and alternative treatments for autism part 1: evidence-supported treatments.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Complementary Therapies; Disease Models, Animal; Evidence-Based Medicine; Free Radical Scavengers; Gastrointestinal Tract; Humans; Inflammation; Mice; Oxidative Stress; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration; Vitamin B 12 | 2015 |
Oral acetylcysteine for neuropsychiatric disorders.
Topics: Acetylcysteine; Administration, Oral; Autistic Disorder; Bipolar Disorder; Complementary Therapies; Dietary Supplements; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Schizophrenia; Trichotillomania | 2015 |
2 trial(s) available for acetylcysteine and Autism
| Article | Year |
|---|---|
A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder.
Topics: Acetylcysteine; Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Treatment Failure | 2017 |
A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
Topics: Acetylcysteine; Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Female; Free Radical Scavengers; Humans; Irritable Mood; Male; Pilot Projects; Stereotyped Behavior; Treatment Outcome | 2012 |
9 other study(ies) available for acetylcysteine and Autism
| Article | Year |
|---|---|
Azoxystrobin Impairs Neuronal Migration and Induces ROS Dependent Apoptosis in Cortical Neurons.
Topics: Acetylcysteine; Animals; Apoptosis; Autistic Disorder; Cell Movement; Cell Survival; Female; Fungicides, Industrial; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mitochondria; Neurogenesis; Neuronal Outgrowth; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Pyrimidines; Reactive Oxygen Species; Strobilurins | 2021 |
N-acetylcysteine improves autism-like behavior by recovering autophagic deficiency and decreasing Notch-1/Hes-1 pathway activity.
Topics: Acetylcysteine; Animals; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Female; Humans; Neuroblastoma; Prenatal Exposure Delayed Effects; Rats; Valproic Acid | 2023 |
Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions.
Topics: Acetylcysteine; Animals; Anxiety; Autistic Disorder; Chromosome Deletion; Chromosomes, Mammalian; Disease Models, Animal; Gene-Environment Interaction; Humans; Male; Mice, Inbred C57BL; Motor Activity; Phenotype; Social Behavior; Social Interaction | 2020 |
N-acetylcysteine is effective as add-on therapy to risperidone-based combination for children with autistic disorders.
Topics: Acetylcysteine; Antipsychotic Agents; Autistic Disorder; Child; Humans; Irritable Mood; Risperidone | 2022 |
N-acetylcysteine ameliorates repetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism.
Topics: Acetylcysteine; Animals; Antioxidants; Autistic Disorder; Behavior, Animal; beta Catenin; Brain; Glutathione; Glycogen Synthase Kinase 3 beta; Male; Malondialdehyde; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Valproic Acid; Wnt Signaling Pathway | 2017 |
Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats.
Topics: Acetylcysteine; Analysis of Variance; Animals; Autistic Disorder; Brain; Comet Assay; Disease Models, Animal; DNA; Gene Expression Regulation; Glutathione Transferase; Interferon-gamma; Male; Neuroprotective Agents; Propionates; Rats; ROC Curve; Serotonin | 2013 |
Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines.
Topics: Acetylcysteine; Autistic Disorder; Cell Line; Child; Glutathione; Humans; Lymphocytes; Male; Mitochondria; Oxidative Stress; Reactive Oxygen Species | 2014 |
N-acetylcysteine as treatment for self-injurious behavior in a child with autism.
Topics: Acetylcysteine; Autistic Disorder; Child, Preschool; Humans; Male; Self-Injurious Behavior | 2014 |
Translating the Rosetta Stone of N-acetylcysteine.
Topics: Acetylcysteine; Autistic Disorder; Behavior; Event-Related Potentials, P300; Evoked Potentials, Auditory; Excitatory Amino Acid Antagonists; Female; Free Radical Scavengers; Humans; Ketamine; Male | 2012 |